We are live on ! Find out more
INSM icon

Insmed
INSM

106 hedge funds and large institutions have $557M invested in Insmed in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more call options, than puts

Call options by funds: $5.71M | Put options by funds: $1.94M

72% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 25

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

5% more funds holding

Funds holding: 101 → 106 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

23% less capital invested

Capital invested by funds: $722M → $557M (-$166M)

Holders
106
Holders Change
+5
Holders Change %
+4.95%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
43
Reduced
25
Closed
11
Calls
$5.71M
Puts
$1.94M
Net Calls
+$3.77M
Net Calls Change
+$2.88M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$8.04M
2
Millennium Management
Millennium Management
New York
+$5.22M
3
Citadel Advisors
Citadel Advisors
Florida
+$4.93M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.26M
5
Axa
Axa
France
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$18.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.87M
3
Invesco
Invesco
Georgia
-$7.17M
4
SAM
Senzar Asset Management
New York
-$3.69M
5
Morgan Stanley
Morgan Stanley
New York
-$3.29M

INSM Hedge Fund Activity: Q2 2016 in Review

106 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2016, worth a combined $557M — down 23% from $722M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new INSM positions and 11 closed out — a net gain of 6 holders — while 43 added to existing stakes and 25 trimmed.

The largest buyer was OrbiMed, adding an estimated $8.04M. The largest seller was Visium Asset Management, cutting an estimated $18.3M.

  • 106 institutional investors held Insmed (INSM) as of Q2 2016, up from 101 in Q1 2016.
  • Funds reported $557M of Insmed stock for Q2 2016, down 23% quarter-over-quarter.
  • 17 funds opened new Insmed positions in Q2 2016 and 11 closed out, a net change of +6 holders.
  • The largest Insmed buyer in Q2 2016 was OrbiMed, an estimated $8.04M added.
  • The largest Insmed seller in Q2 2016 was Visium Asset Management, an estimated $18.3M sold.

Based on aggregated 13F filings for Q2 2016.